Company Filing History:
Years Active: 2008
Title: Nicole Martin - Innovator in Cancer Research
Introduction
Nicole Martin is a prominent inventor based in Montréal, Canada. She has made significant contributions to the field of cancer research, particularly in understanding predispositions to breast cancer. Her innovative work has the potential to impact many lives by providing early detection methods for this serious disease.
Latest Patents
Nicole Martin holds a patent for her invention titled "Methods for determining a predisposition to develop breast adenocarcinoma or breast inflammatory carcinoma." This invention relates to a method for determining a patient's predisposition to develop cancer by detecting the EN2 gene or its expression product in biological samples. The presence of the EN2 gene or its expression product indicates a predisposition to breast cancer. Additionally, her patent includes antisense hybridization kits for determining predisposition to cancer and methods for reducing EN2 expression.
Career Highlights
Nicole is affiliated with the Institut de Recherche Clinique de Montréal, where she conducts her research. Her work is crucial in advancing the understanding of genetic factors in cancer development. With her innovative approach, she aims to improve early detection and treatment options for patients at risk of breast cancer.
Collaborations
Nicole collaborates with esteemed colleagues such as Guy Sauvageau and Sylvain Meloche. Their combined expertise enhances the research efforts at the Institut de Recherche Clinique de Montréal, fostering an environment of innovation and discovery.
Conclusion
Nicole Martin is a dedicated inventor whose work in cancer research is paving the way for new methods of early detection and treatment. Her contributions are vital in the fight against breast cancer, and her innovative spirit continues to inspire others in the field.